Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 161 | 53 | 51 | 13 | 98 |
| Cost of Goods | 87 | 18 | 15 | 10 | 46 |
| Gross Profit | 75 | 35 | 36 | 3 | 52 |
| Operating Expenses | 737 | 646 | 701 | 775 | 720 |
| Operating Income | -662 | -611 | -665 | -772 | -668 |
| Interest Expense | 61 | 52 | 48 | 36 | 32 |
| Other Income | 40 | 1 | -3 | 4 | -1 |
| Pre-tax Income | -683 | -662 | -716 | -804 | -701 |
| Net Income Continuous | -683 | -662 | -716 | -804 | -701 |
| Net Income | $-683 | $-662 | $-716 | $-804 | $-701 |
| EPS Basic Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-589 | $-577 | $-634 | $-733 | $-634 |